EarningsstocksAI Generated

Cardinal Health Reports Strong FY2026 Results, Maintains "Buy" Rating

By rawfin.tv Markets Desk|October 1, 2026, 00:49 UTC|Updated October 13, 2026, 13:00 UTC|1 min read|AI-assisted · Methodology

Cardinal Health (CAH) announced robust fiscal year 2026 results, showcasing significant revenue growth and improved gross margins. The company also provided optimistic earnings growth guidance for FY2027, leading analysts to maintain a "Buy" rating on its stock.

Cardinal HealthEarningsHealthcareAnalyst RatingsStock Performance

Cardinal Health Reports Strong FY2026 Results, Maintains "Buy" Rating

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

EQT to Acquire Cleanaway Waste for $6.5 Billion

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008